coronavirus
cov
positivesens
rna
virus
infect
numer
mammalian
avian
speci
capabl
caus
sever
lethal
diseas
human
cov
encod
sever
innat
immun
antagonist
interact
host
innat
immun
respons
facilit
effici
viral
replic
cov
nonstructur
protein
encod
exoribonucleas
activ
exon
perform
proofread
function
requir
highfidel
replic
outsid
order
nidoviral
arenavirus
rna
virus
encod
exon
function
degrad
dsrna
replic
intermedi
studi
test
hypothesi
cov
exon
may
also
function
antagon
innat
immun
respons
demonstr
virus
lack
exon
activ
exon
sensit
cellular
pretreat
interferon
beta
dosedepend
manner
addit
exon
viru
replic
attenu
wildtyp
bone
marrowderiv
macrophag
bmm
partial
restor
interferon
alphabeta
receptor
defici
ifnar
bmm
exon
viru
replic
result
gene
express
presenc
antivir
state
exon
viral
rna
level
substanti
reduc
rel
untreat
howev
exon
viru
gener
pretreat
cell
reduc
specif
infect
decreas
rel
fit
suggest
exon
viru
gener
antivir
state
less
viabl
establish
subsequ
infect
overal
data
suggest
mhv
exon
activ
requir
resist
innat
immun
respons
antivir
mechan
affect
viral
rna
sequenc
andor
rna
modif
act
virus
lack
exon
activ
right
reserv
reus
allow
without
permiss
wildtyp
bone
marrow
deriv
macrophag
bmm
restor
interferon
alphabeta
receptor
defici
ifnar
bmm
despit
increas
sensit
effect
ifn
treatment
mhv
exon
mutant
fail
induc
detect
gene
express
rnase
mediat
ribosom
rna
rrna
degrad
limit
decreas
viral
rna
accumul
observ
final
exon
viru
replic
presenc
mediat
antivir
state
decreas
specif
infect
decreas
rel
fit
compar
untreat
exon
viru
thu
exon
appear
block
correct
restrict
mhv
infect
ifnmedi
mechan
may
involv
damag
nascent
viral
rna
affect
subsequ
infect
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
virus
lack
exon
activ
sensit
effect
bind
type
interferon
ifnar
receptor
cell
surfac
lead
jakstat
signal
cascad
ultim
result
upregul
express
hundr
antivir
isg
addit
wtmhv
replic
shown
rel
resist
effect
ifn
determin
whether
exon
activ
mhv
requir
resist
ifn
pretreat
murin
delay
brain
tumor
dbt
cell
increas
concentr
mous
h
prior
infect
wtmhv
exon
viru
multipl
infect
moi
plaqueform
unit
pfu
per
cell
fig
respons
pretreat
wtmhv
viral
titer
decreas
approxim
log
previous
report
contrast
exon
viral
titer
demonstr
dosedepend
decreas
result
approxim
log
decreas
viral
titer
rel
untreat
exon
viral
titer
exon
activ
confer
activ
site
residu
present
differ
motif
within
exon
domain
therefor
determin
whether
observ
sensit
pretreat
exon
viru
fig
due
specif
absenc
exon
activ
engin
recov
viru
encod
aspart
acid
alanin
substitut
motif
iii
previous
demonstr
virus
lack
exon
activ
decreas
replic
fidel
sensit
rna
mutagen
fluorouracil
henc
sensit
vitro
indic
exon
activ
therefor
first
test
whether
exon
demonstr
similar
sensit
fu
ensur
exon
activ
viru
ablat
similar
exon
viral
replic
cell
treat
increas
concentr
demonstr
dosedepend
decreas
viral
titer
rel
vehicl
treat
cell
fig
exon
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
display
similar
sensit
pretreat
uml
follow
infect
moi
pfucel
fig
thu
data
suggest
exon
activ
requir
resist
effect
regul
express
isg
increas
replic
capac
confer
resist
effect
pretreat
virus
lack
exon
activ
exon
viru
demonstr
approxim
h
delay
exponenti
replic
log
decreas
peak
titer
rel
therefor
test
whether
ifn
sensit
phenotyp
observ
exon
virus
due
decreas
replic
capac
virus
util
exon
viru
develop
lab
blindli
passag
dbt
cell
passag
exon
replic
capac
result
exon
viru
exce
wtmhv
fig
howev
despit
increas
replic
capac
exon
demonstr
similar
sensit
pretreat
exon
viru
fig
b
henc
sensit
phenotyp
virus
lack
exon
activ
depend
viral
replic
capac
instead
directli
associ
specif
function
exon
requir
effici
replic
presenc
antivir
state
exon
activ
requir
replic
wildtyp
bmm
next
want
test
whether
exon
activ
requir
ifn
resist
primari
innat
immun
cell
bmm
replic
wtmhv
primari
bmm
well
describ
data
suggest
wildtyp
bmm
express
mani
prr
isg
higher
basal
level
mani
mous
cell
line
contrast
bmm
lack
ifnar
receptor
ifnar
lower
basal
express
level
isg
thu
make
ifnarbmm
excel
cell
type
interrog
role
exon
activ
viral
replic
antagon
innat
immun
respons
bmm
ifnarmic
gener
infect
wtmhv
exon
viru
moi
pfucel
sampl
harvest
indic
time
point
viral
titer
determin
plaqu
assay
fig
rnase
lpkr
defici
upon
detect
pathogenassoci
molecular
pattern
pamp
innat
sensor
signal
pathway
lead
transcript
factor
activ
nuclear
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
transloc
result
express
mrna
wtmhv
well
known
prevent
delay
induct
ifn
express
howev
exon
activ
may
help
prevent
detect
pamp
name
dsrna
shown
increas
endou
mutant
therefor
determin
whether
loss
exon
activ
result
gener
subsequ
detect
pamp
determin
level
gene
express
dbt
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
h
postinfect
howev
viral
yield
minim
data
suggest
loss
exon
activ
lead
transcript
activ
notabl
dsrna
sensor
oasrnas
l
infect
dbt
cell
addit
bmm
defici
antivir
effector
rnase
l
pkr
suffici
restor
exon
viral
replic
ifn
treatment
substanti
alter
exon
viral
rna
accumul
particl
releas
sinc
exon
activ
requir
resist
ifn
effect
ifn
induct
sought
discern
stage
viral
replic
restrict
treatment
reduct
viral
rna
could
explain
small
portion
ifn
phenotyp
data
suggest
decreas
replic
transcript
primari
driver
exon
ifn
sensit
sinc
pretreat
dbt
cell
grossli
alter
exon
viral
rna
accumul
reduc
exon
viral
titer
sought
determin
whether
ifn
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
copyright
holder
preprint
peerreview
authorfund
copyright
holder
preprint
peerreview
authorfund
cov
encod
multipl
ifn
antagonist
prevent
induct
mediat
resist
innat
immun
respons
thu
allow
effici
viral
replic
earli
infect
moreov
insuffici
innat
immun
respons
propos
major
contributor
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
sarscov
pathogenesi
studi
sought
determin
contribut
exon
activ
induct
resist
innat
immun
respons
demonstr
exon
viru
sensit
pretreat
exon
virus
also
sensit
effect
ifn
conclud
ifn
sensit
specif
due
loss
exon
activ
experi
perform
howev
one
would
expect
endonucleolyt
product
smaller
dsrna
could
still
activ
rigi
similar
rnase
l
product
unless
anoth
rna
degrad
mechan
place
addit
despit
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
intact
phosphodiesteras
mutant
still
activ
rnase
lmediat
rrna
degrad
lastli
rnasel
pkr
bmm
infect
exon
viru
viral
replic
rescu
suggest
rnase
l
pkr
requir
exon
viru
restrict
fig
moreov
data
suggest
dsrna
detect
antivir
interestingli
tgev
exon
activ
site
mutant
nonviabl
although
first
report
nonviabl
exon
activ
site
residu
mutant
alphacoronavirus
initi
report
cov
exon
activ
human
cov
exon
activ
site
mutant
also
nonviabl
suggest
common
essenti
function
exon
alphacoronaviru
replic
andor
innat
antagon
altogeth
possibl
common
innat
immun
antagon
function
across
alphaand
betacov
appar
clearli
differ
requir
exist
may
depend
cov
genu
cell
type
use
result
clearli
demonstr
virus
lack
exon
activ
sensit
pretreat
dosedepend
manner
fig
c
fig
replic
virus
lack
exon
activ
depend
capac
bmm
express
gene
downstream
ifnar
signal
fig
due
fact
ifnarcel
differ
level
basal
isg
express
thu
two
differ
intracellular
environ
viral
replic
occur
ifnarbmm
exon
exon
viru
replic
capac
restor
level
approach
exceed
wtmhv
level
fig
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
specif
infect
fig
coinfect
fig
data
show
exon
viru
gener
presenc
antivir
state
less
viabl
upon
subsequ
infect
altogeth
result
suggest
isg
isg
act
exon
viru
specif
result
progeni
less
viabl
upon
subsequ
infect
thu
interest
determin
specif
isg
isg
respons
mediat
observ
restrict
addit
import
determin
whether
greater
proport
incom
exon
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
sinc
cov
encod
largest
genom
known
rna
virus
luxuri
encod
multipl
ifn
antagonist
limit
capac
cell
detect
respond
infect
collect
data
suggest
mhv
exon
activ
contributor
cov
innat
immun
antagon
clearli
demonstr
virus
lack
exon
activ
sensit
effect
antivir
state
data
reveal
critic
role
exon
activ
cov
replic
provid
addit
rational
target
exon
activ
mean
viral
attenu
futur
studi
probe
specif
mechan
restrict
virus
lack
exon
activ
assess
requir
exon
activ
resist
innat
immun
util
treatment
human
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
bmm
infect
viru
moi
pfucel
h
incub
inocula
remov
cell
wash
time
pb
fresh
medium
ad
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
cell
transfect
polyi
c
sigma
use
lipofectamin
thermo
fisher
scientif
total
rna
sampl
purifi
use
purelink
rna
mini
purif
system
life
technolog
follow
manufactur
instruct
upon
purif
total
rna
analyz
agil
bioanalyz
vanderbilt
vantag
core
facil
rrna
integr
report
quantif
viral
genom
rna
qrtpcr
quantif
viral
genom
rna
previous
describ
briefli
rna
standard
prepar
use
mhv
fragment
standard
curv
gener
use
dilut
copi
fam
label
probe
biosearch
technolog
use
forward
revers
specif
primer
final
volum
reaction
nm
probe
nm
primer
sampl
rna
toughmix
onestep
low
rox
enzym
mix
quanta
per
reaction
sampl
quantifi
use
appli
bioscienc
realtim
pcr
system
condit
min
min
min
last
two
step
repeat
time
standard
curv
plot
use
graphpad
prism
softwar
calcul
quantif
subgenom
rna
qpcr
subconflu
dbt
cell
treat
uml
mous
h
prior
infect
viru
moi
pfucel
min
incub
inocula
remov
cell
wash
pb
fresh
medium
ad
indic
time
postinfect
cell
cultur
supernat
remov
total
rna
harvest
ad
trizol
reagent
total
rna
extract
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
use
purelink
rna
mini
purif
system
follow
manufactur
instruct
cdna
gener
rtpcr
use
total
rna
previous
describ
purif
system
genom
rna
quantifi
use
onestep
qrtpcr
describ
particl
pfu
ratio
calcul
coinfect
assay
subconflu
monolay
dbt
cell
treat
uml
mous
h
prior
infect
viru
moi
pfucel
min
incub
inocula
remov
cell
wash
pb
fresh
medium
ad
h
postinfect
cell
cultur
supernat
remov
supernat
ad
trizol
reagent
viral
genom
rna
purifi
number
viral
genom
rna
copi
present
rel
rna
standard
curv
determin
describ
base
number
viral
genom
rna
copi
determin
qrtpcr
equal
number
viru
particl
viru
condit
combin
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
copyright
holder
preprint
peerreview
authorfund
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
treatment
group
mix
equal
number
wt
silent
exon
silent
viru
particl
mixtur
use
infect
fresh
monolay
untreat
dbt
cell
h
infect
cell
cultur
supernat
collect
rna
extract
number
virion
genom
rna
copi
origin
viru
treatment
group
rel
respect
silent
standard
virus
determin
onestep
qrtpcr
report
chang
fit
rel
silent
viru
standard
error
bar
repres
sem
panel
statist
signific
compar
untreat
wtmhv
exon
infect
respect
denot
determin
student
test
p
p
ns
signific
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
